Effects of Subinhibitory Concentrations of Antibiotics on Colonization Factor Expression by Moxifloxacin-Susceptible and Moxifloxacin-Resistant Clostridium difficile Strains

被引:34
作者
Deneve, Cecile [1 ]
Bouttier, Sylvie [1 ]
Dupuy, Bruno [2 ]
Barbut, Frederic [3 ]
Collignon, Anne [1 ,4 ]
Janoir, Claire [1 ]
机构
[1] Univ Paris 11, Fac Pharm, Dept Microbiol, EA 4043, F-92296 Chatenay Malabry, France
[2] Inst Pasteur, Unite Toxines & Pathogenie Bacterienne, F-75724 Paris 15, France
[3] Univ Paris 06, Hop St Antoine, AP HP, EA 2392, Paris, France
[4] Hop Jean Verdier, Microbiol Serv, AP HP, Bondy, France
关键词
SURFACE-LAYER PROTEINS; FIBRONECTIN-BINDING PROTEINS; SUB-MIC CONCENTRATIONS; TOXIN PRODUCTION; STAPHYLOCOCCUS-AUREUS; ANTIBODY-RESPONSE; GENE-EXPRESSION; CECAL CONTENTS; NORTH-AMERICA; CELL-SURFACE;
D O I
10.1128/AAC.00532-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent outbreaks of Clostridium difficile infection have been related to the emergence of the NAP1/027 epidemic strain. This strain demonstrates increased virulence and resistance to the C-8-methoxyfluoroquinolones gatifloxacin and moxifloxacin. These antibiotics have been implicated as major C. difficile infection-inducing agents. We investigated by real-time reverse transcription-PCR the impact of subinhibitory concentrations of ampicillin, clindamycin, ofloxacin, and moxifloxacin on the expression of genes encoding three colonization factors, the protease Cwp84, the high-molecular-weight S-layer protein, and the fibronectin-binding protein Fbp68. We have previously shown in six non-NAP1/027 moxifloxacin-susceptible strains that the presence of ampicillin or clindamycin induced an upregulation of these genes, whereas the presence of fluoroquinolones did not. The objective of this study was to analyze the expression of these genes under the same conditions in four NAP1/027 strains, one moxifloxacin susceptible and three moxifloxacin resistant. Two in vitro-selected moxifloxacin-resistant mutants were also analyzed. Moxifloxacin resistance was associated with the Thr823 -> Ile substitution in GyrA in all but one of the moxifloxacin-resistant strains. The expression of cwp84 and slpA was strongly increased after culture with ampicillin or clindamycin in NAP1/027 strains. Interestingly, after culture with fluoroquinolones, the expression of cwp84 and slpA was only increased in four moxifloxacin-resistant strains, including the NAP1/027 strains and one of the in vitro-selected mutants. The overexpression of cwp84 was correlated with increased production of the protease Cwp84. The historical NAP1/027 moxifloxacin-susceptible strain and its mutant appear to be differently regulated by fluoroquinolones. Overall, fluoroquinolones appear to favor the expression of some colonization factor-encoding genes in resistant C. difficile strains. The fluoroquinolone resistance of the NAP1/027 epidemic strains could be considered an ecological advantage. This could also increase their colonization fitness and promote the infection.
引用
收藏
页码:5155 / 5162
页数:8
相关论文
共 57 条
[1]   Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA [J].
Ackermann, G ;
Tang, YJ ;
Kueper, R ;
Heisig, P ;
Rodloff, AC ;
Silva, J ;
Cohen, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2348-2353
[2]   Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile [J].
Ackermann, G ;
Tang-Feldman, YJ ;
Schaumann, R ;
Henderson, JP ;
Rodloff, AC ;
Silva, J ;
Cohen, SH .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) :526-530
[3]   Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the Cecal contents of mice [J].
Adams, Daniel A. ;
Riggs, Michelle M. ;
Donskey, Curtis J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) :2674-2678
[4]   Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model [J].
Baines, SD ;
Freeman, J ;
Wilcox, MH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :974-982
[5]   Moxifloxacin therapy as a risk factor for clostridium difficile-associated disease during an outbreak: Attempts to control a new epidemic strain [J].
Biller, Priscilla ;
Shank, Beth ;
Lind, Leah ;
Brennan, Meghan ;
Tkatch, Lisa ;
Killgore, George ;
Thompson, Angela ;
McDonald, L. Clifford .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (02) :198-201
[6]   Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin [J].
Bisognano, C ;
Vaudaux, PE ;
Lew, DP ;
Ng, EYW ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :906-913
[7]   Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin [J].
Bisognano, C ;
Vaudaux, P ;
Rohner, P ;
Lew, DP ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1428-1437
[8]   Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues [J].
Calabi, E ;
Calabi, F ;
Phillips, AD ;
Fairweather, NF .
INFECTION AND IMMUNITY, 2002, 70 (10) :5770-5778
[9]   Molecular characterization of the surface layer proteins from Clostridium difficile [J].
Calabi, E ;
Ward, S ;
Wren, B ;
Paxton, T ;
Panico, M ;
Morris, H ;
Dell, A ;
Dougan, G ;
Fairweather, N .
MOLECULAR MICROBIOLOGY, 2001, 40 (05) :1187-1199
[10]   PURIFICATION AND CHARACTERIZATION OF AN IMMUNODOMINANT-36 KDA ANTIGEN PRESENT ON THE CELL-SURFACE OF CLOSTRIDIUM-DIFFICILE [J].
CERQUETTI, M ;
PANTOSTI, A ;
STEFANELLI, P ;
MASTRANTONIO, P .
MICROBIAL PATHOGENESIS, 1992, 13 (04) :271-279